Prostate Specific Antigen Decrease and Prostate Cancer Diagnosis: Antibiotic Versus Placebo Prospective Randomized Clinical Trial

Journal of Urology

Volumn 183, Issue 3, 2010, Pages 940-945

  Stopiglia, R M ^a   Ferreira, U ^a   Silva Jr , M M ^a   Matheus, W E ^a   Denardi, F ^a   Reis, L O ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

biopsy; prospective studies; prostatic neoplasms; prostatitis

Indexed keywords

CIPROFLOXACIN; PLACEBO; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATITIS; RANDOMIZED CONTROLLED TRIAL; TRANSRECTAL ULTRASONOGRAPHY;

AGED; ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS;

EID: 75849116352     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.11.044     Document Type: Article

References (26)

1. Krieger J.N., Nyberg Jr. L., and Nickel J.C. NIH consensus definition and classification of prostatitis. JAMA 282 (1999) 236
2. Nickel J.C., Nyberg L.M., and Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology 54 (1999) 229
3. Potts J.M. Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol 164 (2000) 1550
4. Terrone C., Poggio M., Bollito E., et al. Asymptomatic prostatitis: a frequent cause of raising PSA. Recenti Prog Med 96 (2005) 365
5. Delongchamps N.B., de la Roza G., Chandan V., et al. Evaluation of prostatitis in autopsied prostates-is chronic inflammation more associated with benign hyperplasia or cancer?. J Urol 179 (2008) 1736
6. Loeb S., Gashti S.N., and Catalona W.J. Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA). Urol Oncol 27 (2009) 64
7. Mears E.M., and Stamey T.A. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 5 (1968) 492
8. Scardino P.T. The responsible use of antibiotics for an elevated PSA level. Nat Clin Pract Urol 4 (2007) 1
9. Kaygisiz O., Ugurlu O., Koşan M., et al. Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml. Prostate Cancer Prostatic Dis 9 (2006) 235
10. Tchetgen M.B., and Oesterling J.E. The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration. Urol Clin North Am 24 (1997) 283
11. Habermacher G.M., Chason J.T., and Schaeffer A.J. Prostatitis/chronic pelvic pain syndrome. Annu Rev Med 57 (2006) 195
12. Zhang L., Loblaw A., and Klotz L. Modeling prostate specific antigen kinetics in patients on active surveillance. J Urol 176 (2006) 1392
13. Komatsu K., Wehner N., Prestigiacomo A.F., et al. Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population. Urology 47 (1996) 343
14. Nadler R.B., Humphrey P.A., Smith D.S., et al. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 154 (1995) 407
15. Stancik I., Luftenegger W., Klimpfinger M., et al. Effect of NIH-IV prostatitis on free and free-to-total PSA. Eur Urol 46 (2004) 760
16. Shimomura T., Kiyota H., Takahashi H., et al. Prostate histopathology of NIH category IV prostatitis detected by sextant prostate needle biopsy from the patients with high prostatic specific antigen. Kansenshogaku Zasshi 77 (2003) 611
17. Gümüş B.H., Neşe N., Gündüz M.I., et al. Does asymptomatic inflammation increase PSA?. A histopathological study comparing benign and malignant tissue biopsy specimens. Int Urol Nephrol 36 (2004) 549
18. Simardi L.H., Tobias-Machado M., Kappaz G.T., et al. Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study. Urology 64 (2004) 1098
19. Bozeman C.B., Carver B.S., Eastham J.A., et al. Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol 167 (2002) 1723
20. Guercio S., Terrone C., Tarabuzzi R., et al. PSA decrease after levofloxacin therapy in patients with histological prostatitis. Arch Ital Urol Androl 76 (2004) 154
21. Serretta V., Catanese A., Daricello G., et al. PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients. Prostate Cancer Prostatic Dis 11 (2008) 148
22. Karazanashvili G., and Managadze L. Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination. Eur Urol 39 (2001) 538
23. Erol H., Beder N., Caliskan T., et al. Can the effect of antibiotherapy and anti-inflammatory therapy on serum PSA levels discriminate between benign and malign prostatic pathologies?. Urol Int 76 (2006) 20
24. Kobayashi M., Nukui A., and Morita T. Serum PSA and percent free PSA value changes after antibiotic treatment. A diagnostic method in prostate cancer suspects with asymptomatic prostatitis. Urol Int 80 (2008) 186
25. Baltaci{dotless} S., Süer E., Haliloglu A.H., et al. Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen. J Urol 181 (2009) 128
26. Thompson I.M., Pauler D.K., Goodman P.J., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < 4.0 ng per milliliter. N Engl J Med 350 (2004) 2239